Fractional flow reserve in acute coronary syndromes and in stable ischemic heart disease: clinical implications

2019 ◽  
Vol 277 ◽  
pp. 42-46 ◽  
Author(s):  
Antonio Maria Leone ◽  
Pio Cialdella ◽  
Francesca Lassandro Pepe ◽  
Eloisa Basile ◽  
Giuseppe Zimbardo ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Fractional Flow Reserve ◽  
Acute Coronary Syndromes ◽  
Ischemic Heart ◽  
Clinical Implications ◽  
Fractional Flow ◽  
Stable Ischemic Heart Disease ◽  
Flow Reserve ◽  
Coronary Syndromes

scholarly journals Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease

2020 ◽  
Vol 75 (4) ◽  
pp. 409-419 ◽  
Author(s):  
Rushi V. Parikh ◽  
Grace Liu ◽  
Mary E. Plomondon ◽  
Thomas S.G. Sehested ◽  
Mark A. Hlatky ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Fractional Flow Reserve ◽  
Ischemic Heart ◽  
Fractional Flow ◽  
Stable Ischemic Heart Disease ◽  
Flow Reserve

scholarly journals SCOT-HEART trial: reshuffling our approach to stable ischemic heart disease

2020 ◽  
Vol 93 (1113) ◽  
pp. 20190763 ◽  
Author(s):  
Sagar B Amin ◽  
Arthur E Stillman
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Standard Care ◽  
Invasive Coronary Angiography ◽  
Diagnostic Testing ◽  
Ischemic Heart ◽  
Fractional Flow ◽  
Stable Ischemic Heart Disease ◽  
Coronary Ct ◽  
Flow Reserve

The role of diagnostic testing in triaging patients with stable ischemic heart disease continues to evolve towards recognizing the benefits of coronary CT angiography (CCTA) over functional testing. The SCOT-HEART (Scottish Computed Tomography of the HEART) trial highlights this paradigm shift finding a significant reduction of death from coronary heart disease or non-fatal myocardial infarction without a significant increased rate of invasive coronary angiography over a 5 year follow-up period when implementing CCTA with standard care vs standard care alone. The better negative predictive value and ability to identify nonobstructive coronary artery disease to optimize medical therapy highlight the benefits of a CCTA first strategy. With the advent of noninvasive fractional flow reserve (FFR) and widespread availability and ease of CT, CCTA continues to establish itself as a pivotal diagnostic exam for patients with stable ischemic heart disease. In this commentary, we review the SCOT-HEART trial and its impact on CCTA for patients with stable ischemic heart disease.

Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes

Heart ◽  
2016 ◽  
Vol 102 (24) ◽  
pp. 1988-1994 ◽  
Author(s):  
Srikanth Kasula ◽  
Shiv Kumar Agarwal ◽  
Yalcin Hacioglu ◽  
Nagavenkata Krishnachand Pothineni ◽  
Sabha Bhatti ◽  
...  
Keyword(s):  
Fractional Flow Reserve ◽  
Acute Coronary Syndromes ◽  
Prognostic Value ◽  
Fractional Flow ◽  
Flow Reserve ◽  
Coronary Syndromes

scholarly journals Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease

2018 ◽  
Vol 72 (18) ◽  
pp. 2123-2134 ◽  
Author(s):  
Bjarne L. Nørgaard ◽  
Christian J. Terkelsen ◽  
Ole N. Mathiassen ◽  
Erik L. Grove ◽  
Hans Erik Bøtker ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart ◽  
Stable Ischemic Heart Disease ◽  
Coronary Ct ◽  
Flow Reserve
Sign in / Sign up

Export Citation Format

Share Document